+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Aesthetic Devices Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 115 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640425
UP TO OFF until Jan 30th 2025
The global medical aesthetic device market was valued at $13,529.6 million in 2020, and is projected to reach $38,916.6 million by 2030, registering a CAGR of 10.7% from 2021 to 2030.
Medical aesthetic is a medical filed, which is focused on procedures and techniques for improving the appearance, texture, and contours of the face, body, and skin by treating various conditions such as moles, excess fat, skin looseness, cellulite, poker, scars, liver spots, wrinkles, cellulite, and unwanted hair. Furthermore, these technologies (especially implants) correct deformities caused by accidents, trauma, and other congenital conditions. Aesthetic medicine includes both surgical and non-surgical techniques, and a combination of both can be utilized to improve a person's physical appearance.

The major factors that drive the growth of the global medical aesthetic device market include technological advancements, high demand for minimally invasive & non-invasive reconstruction surgeries, rise in incidence of congenital face & tooth deformities, and surge in awareness for aesthetic appearance. However, high costs of treatment, low reimbursements, and risk of malfunctions associated with implants restrict the market growth.

The global medical aesthetic device market is segmented into type of product, application, end user, and region. By product type, the market is divided into devices and aesthetic implants. On the basis of application, it is bifurcated into surgical and non-surgical. Depending on end user, it is segregated into hospitals & clinics and medical spas & beauty centers. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include the Allergan PLC, Solta Medical, Syneron Medical Ltd., Cynosure Inc., Lumenis Ltd. Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Alma Lasers Ltd. (acquired by Shanghai Fosun Pharmaceutical (Group) Co., GC Aesthetics Plc., Sientra Inc., Zimmer Biomet Holdings, Inc., and Dentsply Sirona Inc.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the market, with current trends and future estimations to elucidate imminent investment pockets.
  • It offers a quantitative analysis and comprehensive analysis of all geographical regions from 2021 to 2030 to enable stakeholders to capitalize on prevailing market opportunities.
  • Analysis based on product type helps understand various types of devices used during a cosmetic procedure.
  • Key players have been profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Key Market Segments


By Product

  • Devices
  • Aesthetic Implants

By Application

  • Surgical
  • Non Surgical

By End User

  • Hospitals And Clinics
  • Medical Spas And Beauty Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Colombia
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • Allergan plc
  • Dentsply Sirona Inc.
  • Johnson & Johnson
  • LUMENIS LTD
  • MERZ PHARMA GMBH & CO. KGAA
  • Hologic, Inc.
  • Sientra Inc
  • SYNERON MEDICAL LTD
  • VALEANT PHARMACEUTICAL INTERNATIONAL, INC
  • Zimmer Biomet Holdings, Inc.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: MEDICAL AESTHETIC DEVICES MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Aesthetic Implants
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: MEDICAL AESTHETIC DEVICES MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Surgical
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Non Surgical
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: MEDICAL AESTHETIC DEVICES MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals And Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Medical Spas And Beauty Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: MEDICAL AESTHETIC DEVICES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 United Kingdom
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Colombia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 Saudi Arabia
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Allergan plc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Dentsply Sirona Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Johnson & Johnson
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 LUMENIS LTD
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 MERZ PHARMA GMBH & CO. KGAA
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Hologic, Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Sientra Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 SYNERON MEDICAL LTD
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 VALEANT PHARMACEUTICAL INTERNATIONAL, INC
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Zimmer Biomet Holdings, Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Medical Aesthetic Devices Market, by Product, 2020-2030, ($Million)
Table 2. Medical Aesthetic Devices Market Revenue, for Devices, by Region, 2020-2030, ($Million)
Table 3. Medical Aesthetic Devices Market Devices by Country, 2020-2030, ($Million)
Table 4. Medical Aesthetic Devices Market Revenue, for Aesthetic Implants, by Region, 2020-2030, ($Million)
Table 5. Medical Aesthetic Devices Market Aesthetic Implants by Country, 2020-2030, ($Million)
Table 6. Global Medical Aesthetic Devices Market, by Application, 2020-2030, ($Million)
Table 7. Medical Aesthetic Devices Market Revenue, for Surgical, by Region, 2020-2030, ($Million)
Table 8. Medical Aesthetic Devices Market Surgical by Country, 2020-2030, ($Million)
Table 9. Medical Aesthetic Devices Market Revenue, for Non Surgical, by Region, 2020-2030, ($Million)
Table 10. Medical Aesthetic Devices Market Non Surgical by Country, 2020-2030, ($Million)
Table 11. Global Medical Aesthetic Devices Market, by End-user, 2020-2030, ($Million)
Table 12. Medical Aesthetic Devices Market Revenue, for Hospitals and Clinics, by Region, 2020-2030, ($Million)
Table 13. Medical Aesthetic Devices Market Hospitals and Clinics by Country, 2020-2030, ($Million)
Table 14. Medical Aesthetic Devices Market Revenue, for Medical Spas and Beauty Centers, by Region, 2020-2030, ($Million)
Table 15. Medical Aesthetic Devices Market Medical Spas and Beauty Centers by Country, 2020-2030, ($Million)
Table 16. Medical Aesthetic Devices Market, by Region, 2020-2030, ($Million)
Table 17. North America Medical Aesthetic Devices Market, by Product, 2020-2030, ($Million)
Table 18. North America Medical Aesthetic Devices Market, by Application, 2020-2030, ($Million)
Table 19. North America Medical Aesthetic Devices Market, by End-user, 2020-2030, ($Million)
Table 20. North America Medical Aesthetic Devices Market, by Country, 2020-2030, ($Million)
Table 21. U.S. Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 22. U.S. Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 23. U.S. Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 24. Canada Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 25. Canada Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 26. Canada Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 27. Mexico Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 28. Mexico Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 29. Mexico Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 30. Europe Medical Aesthetic Devices Market, by Product, 2020-2030, ($Million)
Table 31. Europe Medical Aesthetic Devices Market, by Application, 2020-2030, ($Million)
Table 32. Europe Medical Aesthetic Devices Market, by End-user, 2020-2030, ($Million)
Table 33. Europe Medical Aesthetic Devices Market, by Country, 2020-2030, ($Million)
Table 34. Germany Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 35. Germany Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 36. Germany Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 37. France Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 38. France Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 39. France Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 40. United Kingdom Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 41. United Kingdom Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 42. United Kingdom Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 43. Italy Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 44. Italy Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 45. Italy Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 46. Spain Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 47. Spain Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 48. Spain Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 49. Rest of Europe Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 50. Rest of Europe Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 51. Rest of Europe Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 52. Asia-Pacific Medical Aesthetic Devices Market, by Product, 2020-2030, ($Million)
Table 53. Asia-Pacific Medical Aesthetic Devices Market, by Application, 2020-2030, ($Million)
Table 54. Asia-Pacific Medical Aesthetic Devices Market, by End-user, 2020-2030, ($Million)
Table 55. Asia-Pacific Medical Aesthetic Devices Market, by Country, 2020-2030, ($Million)
Table 56. Japan Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 57. Japan Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 58. Japan Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 59. China Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 60. China Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 61. China Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 62. India Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 63. India Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 64. India Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 65. South Korea Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 66. South Korea Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 67. South Korea Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 68. Australia Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 69. Australia Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 70. Australia Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 71. Rest of Asia-Pacific Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 72. Rest of Asia-Pacific Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 73. Rest of Asia-Pacific Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 74. LAMEA Medical Aesthetic Devices Market, by Product, 2020-2030, ($Million)
Table 75. LAMEA Medical Aesthetic Devices Market, by Application, 2020-2030, ($Million)
Table 76. LAMEA Medical Aesthetic Devices Market, by End-user, 2020-2030, ($Million)
Table 77. LAMEA Medical Aesthetic Devices Market, by Country, 2020-2030, ($Million)
Table 78. Brazil Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 79. Brazil Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 80. Brazil Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 81. Colombia Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 82. Colombia Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 83. Colombia Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 84. Saudi Arabia Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 85. Saudi Arabia Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 86. Saudi Arabia Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 87. Rest of LAMEA Medical Aesthetic Devices Market by Product 2020-2030, ($Million)
Table 88. Rest of LAMEA Medical Aesthetic Devices Market by Application 2020-2030, ($Million)
Table 89. Rest of LAMEA Medical Aesthetic Devices Market by End-user 2020-2030, ($Million)
Table 90. Allergan plc: Company Snapshot
Table 91. Allergan plc: Operating Segments
Table 92. Allergan plc: Product Portfolio
Table 93. Allergan plc: Net Sales
Table 94. Allergan plc: Key Stratergies
Table 95. Dentsply Sirona Inc.: Company Snapshot
Table 96. Dentsply Sirona Inc.: Operating Segments
Table 97. Dentsply Sirona Inc.: Product Portfolio
Table 98. Dentsply Sirona Inc.: Net Sales
Table 99. Dentsply Sirona Inc.: Key Stratergies
Table 100. Johnson & Johnson: Company Snapshot
Table 101. Johnson & Johnson: Operating Segments
Table 102. Johnson & Johnson: Product Portfolio
Table 103. Johnson & Johnson: Net Sales
Table 104. Johnson & Johnson: Key Stratergies
Table 105. Lumenis Ltd: Company Snapshot
Table 106. Lumenis Ltd: Operating Segments
Table 107. Lumenis Ltd: Product Portfolio
Table 108. Lumenis Ltd: Net Sales
Table 109. Lumenis Ltd: Key Stratergies
Table 110. Merz Pharma GmbH & Co. KGaA: Company Snapshot
Table 111. Merz Pharma GmbH & Co. KGaA: Operating Segments
Table 112. Merz Pharma GmbH & Co. KGaA: Product Portfolio
Table 113. Merz Pharma GmbH & Co. KGaA: Net Sales
Table 114. Merz Pharma GmbH & Co. KGaA: Key Stratergies
Table 115. Hologic, Inc.: Company Snapshot
Table 116. Hologic, Inc.: Operating Segments
Table 117. Hologic, Inc.: Product Portfolio
Table 118. Hologic, Inc.: Net Sales
Table 119. Hologic, Inc.: Key Stratergies
Table 120. Sientra Inc: Company Snapshot
Table 121. Sientra Inc: Operating Segments
Table 122. Sientra Inc: Product Portfolio
Table 123. Sientra Inc: Net Sales
Table 124. Sientra Inc: Key Stratergies
Table 125. Syneron Medical Ltd: Company Snapshot
Table 126. Syneron Medical Ltd: Operating Segments
Table 127. Syneron Medical Ltd: Product Portfolio
Table 128. Syneron Medical Ltd: Net Sales
Table 129. Syneron Medical Ltd: Key Stratergies
Table 130. Valeant Pharmaceutical International, Inc: Company Snapshot
Table 131. Valeant Pharmaceutical International, Inc: Operating Segments
Table 132. Valeant Pharmaceutical International, Inc: Product Portfolio
Table 133. Valeant Pharmaceutical International, Inc: Net Sales
Table 134. Valeant Pharmaceutical International, Inc: Key Stratergies
Table 135. Zimmer Biomet Holdings, Inc.: Company Snapshot
Table 136. Zimmer Biomet Holdings, Inc.: Operating Segments
Table 137. Zimmer Biomet Holdings, Inc.: Product Portfolio
Table 138. Zimmer Biomet Holdings, Inc.: Net Sales
Table 139. Zimmer Biomet Holdings, Inc.: Key Stratergies
LIST OF FIGURES
Figure 1. Medical Aesthetic Devices Market Segmentation
Figure 2. Medical Aesthetic Devices Market, 2020-2030
Figure 3. Medical Aesthetic Devices Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Medical Aesthetic Devices Market:Drivers, Restraints and Opportunities
Figure 11. Medical Aesthetic Devices Market, by Product, 2020 (%)
Figure 12. Comparative Share Analysis of Devices Medical Aesthetic Devices Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Aesthetic Implants Medical Aesthetic Devices Market, 2020-2030 (%)
Figure 14. Medical Aesthetic Devices Market, by Application, 2020 (%)
Figure 15. Comparative Share Analysis of Surgical Medical Aesthetic Devices Market, 2020-2030 (%)
Figure 16. Comparative Share Analysis of Non Surgical Medical Aesthetic Devices Market, 2020-2030 (%)
Figure 17. Medical Aesthetic Devices Market, by End-user, 2020 (%)
Figure 18. Comparative Share Analysis of Hospitals and Clinics Medical Aesthetic Devices Market, 2020-2030 (%)
Figure 19. Comparative Share Analysis of Medical Spas and Beauty Centers Medical Aesthetic Devices Market, 2020-2030 (%)
Figure 20. Medical Aesthetic Devices Market by Region, 2020
Figure 21. U.S. Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 22. Canada Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 23. Mexico Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 24. Germany Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 25. France Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 26. United Kingdom Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 27. Italy Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 28. Spain Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 29. Rest of Europe Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 30. Japan Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 31. China Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 32. India Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 33. South Korea Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 34. Australia Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 35. Rest of Asia-Pacific Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 36. Brazil Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 37. Colombia Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 38. Saudi Arabia Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 39. Rest of LAMEA Medical Aesthetic Devices Market, 2020-2030 ($Million)
Figure 40. Top Winning Strategies, by Year
Figure 41. Top Winning Strategies, by Development
Figure 42. Top Winning Strategies, by Company
Figure 43. Product Mapping of Top 10 Players
Figure 44. Competitive Dashboard
Figure 45. Competitive Heatmap of Top 10 Key Players
Figure 46. Allergan PLC.: Net Sales, ($Million)
Figure 47. Dentsply Sirona Inc. Net Sales, ($Million)
Figure 48. Johnson & Johnson.: Net Sales, ($Million)
Figure 49. Lumenis Ltd.: Net Sales, ($Million)
Figure 50. Merz Pharma GmbH & Co. KGaA.: Net Sales, ($Million)
Figure 51. Hologic, Inc. Net Sales, ($Million)
Figure 52. Sientra Inc.: Net Sales, ($Million)
Figure 53. Syneron Medical Ltd.: Net Sales, ($Million)
Figure 54. Valeant Pharmaceutical International, Inc.: Net Sales, ($Million)
Figure 55. Zimmer Biomet Holdings, Inc. Net Sales, ($Million)

Executive Summary

According to this report titled, 'Medical Aesthetic Devices Market,' the medical aesthetic devices market was valued at $13.5 billion in 2020, and is estimated to reach $38.9 billion by 2030, growing at a CAGR of 10.7% from 2021 to 2030.

Medical aesthetics are used to treat and improve a person's aesthetic look by addressing issues such skin laxity, excess fat, cellulite, scars, moles, wrinkles, undesired hair, liver spots, spider veins, and skin discoloration, among others. Dermatology, dental & maxillofacial surgery, reconstructive surgery, and plastic surgery are all traditionally included. Aesthetic medicine includes both surgical and non-surgical techniques, and a combination of both can be utilized to improve a person's physical appearance. Aesthetic devices are utilized to correct deformities caused by accidents, trauma, and other congenital illnesses (particularly implants).

Increase in demand for minimally invasive & noninvasive reconstruction surgeries, technological advancements, surge in incidence of congenital face & tooth deformities, and increase in awareness about aesthetic appearance are expected to drive the medical aesthetic industry. However, high costs of treatment, low reimbursements, and risk of malfunctions are expected to impede the medical aesthetic market growth.

On the basis of product type, the medical aesthetic market size is categorized as into devices and aesthetic implants. The aesthetic implants segment is expected to dominate the market during the forecast period, due to increase in awareness about cosmetic procedures. This upsurge the demand for medical aesthetic industry, and surge the growth of the market. The device segment is expected to register a CAGR of 11.1% during the forecast period, owing to factors such as rise in aging population, availability of consumer-friendly devices, and increase in trend to look aesthetically appealing.

Depending on application, the non-surgical segment accounted for a major share of the market in the medical aesthetic devices market in 2020, as non-surgical medical aesthetic procedures are more accessible and affordable when compared with surgical procedures.

On the basis of end user, the hospitals segment presently dominates the market, and is expected to remain dominant during the forecast period. This is attributed to the fact that hospitals & clinics have installed latest technologically advanced devices and products to provide effective yet minimally invasive cosmetic reconstruction methods. In addition, hospitals provide almost all types of cosmetic procedures for patients, which drives the growth of market.

North America accounted for more than 10.5% of the medical aesthetic market share in 2020, and is expected to remain dominant during the forecast period. This was attributed to well-established healthcare system, increase in number of geriatric patients, and supportive reimbursement policies in healthcare system. Asia-Pacific is projected to register the highest CAGR of 11.7% during the medical aesthetic market forecast period. Strong local economies, active marketing by prominent U.S. and European businesses in Asia, increase in medical tourism, and rise in awareness about medical aesthetics are expected to offer lucrative opportunities for the market growth during the forecast period.

The major companies profiled in the report include Allergan PLC, Solta Medical Inc. Syneron Medical Ltd., Cynosure Inc., Lumenis Ltd. Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Alma Lasers Ltd. (acquired by Shanghai Fosun Pharmaceutical (Group) Co., GC Aesthetics Plc., Sientra Inc., Zimmer Biomet Holdings, Inc., Dentsply Sirona Inc.

KEY FINDINGS OF STUDY

  • The aesthetic implants segment accounted for a share of three-fourths of the total market in 2020.
  • The non-surgical segment is estimated to register CAGR of 11.1% from 2020 to 2030.
  • The hospitals & clinics accounted for more than three-fifths of the total market in 2020.

Companies Mentioned

  • Allergan plc
  • Dentsply Sirona Inc.
  • Johnson & Johnson
  • LUMENIS LTD
  • MERZ PHARMA GMBH & CO. KGAA
  • Hologic, Inc.
  • Sientra Inc
  • SYNERON MEDICAL LTD
  • VALEANT PHARMACEUTICAL INTERNATIONAL, INC
  • Zimmer Biomet Holdings, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information